APOE and Alzheimer disease: Additionally, sex differences in the effects of APOE4 on AD risk are well documented, with female carriers being affected earlier and in higher numbers than male carriers, though both sexes experience elevated risk relative to non-carriers [5, 6], a finding additionally dependent on age [7].